Experience

Brandon Capital

• Australia
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Partner

  • Mar 2022 - 1 year 10 months

  Melbourne, Victoria, Australia

• Investment Director

  • Dec 2020 - Mar 2022

• Senior Investment Manager

  • Dec 2017 - Dec 2020

  Melbourne, Australia

• Investment Manager

  • Nov 2012 - Dec 2017

  Melbourne, Australia



Denteric Pty Ltd

• Director

  • Jun 2019 - 4 years 7 months

  Melbourne, Australia



Paragen Bio

• India
• Biotechnology Research

• Director

  • Jun 2018 - 5 years 7 months

  Queensland, Australia



Okogen, Inc.

• United States
• Biotechnology Research
• 1 - 100 Employee

• Director

  • Dec 2017 - 6 years 1 month

  Greater San Diego Area Okogen is a developer of innovative ophthalmic anti-infectives



MecRx Pty Ltd

• Director

  • Apr 2017 - 6 years 9 months

  Melbourne, Australia MecRx is a drug discovery company developing small molecule inhibitors of cMyc for cancer

• Executive Director

  • Jun 2015 - Apr 2017

  Melbourne, Australia MecRx is a drug discovery company developing small molecule inhibitors of cMyc for cancer



Aravax

• Australia
• Biotechnology Research
• 1 - 100 Employee

• Director

  • Oct 2016 - 7 years 3 months

  Melbourne, Australia Aravax is a clinical-stage biotechnology company developing the first safe and rapidly effective treatment for peanut allergy

• Executive Director

  • May 2015 - Oct 2016

  Melbourne, Australia Aravax is a clinical-stage biotechnology company developing the first safe and rapidly effective treatment for peanut allergy.



Ena Therapeutics Pty Ltd

• Director

  • May 2016 - 7 years 8 months

  Melbourne, Australia Aiming to transform the treatment and prevention of respiratory infections using proprietary TLR2 agonist



Q-Sera

• Research Services

• Executive Director

  • Nov 2012 - 11 years 2 months

  Melbourne, Australia Q-Sera is developing proprietary prothombin activators in blood collection tubes to produce rapidly clotting and high quality serum.



Solvanix

• Australia
• Research

• Executive Director

  • Nov 2014 - 9 years 2 months

  Sydney, Australia Solvanix is a biotechnology company with a novel technology for improving stability and reducing the aggregation of fully human antibodies.



CSL

• Brazil
• Industrial Machinery Manufacturing
• 1 - 100 Employee

• Business Development Manager

  • Jan 2011 - Nov 2012

  Melbourne, Australia

• Manager New Product Opportunities

  • Jan 2009 - May 2012


Judge Business School
• United Kingdom
• Higher Education
• 300 - 400 Employee
• MBA student

  • Sep 2007 - Dec 2008

University of Cambridge
• United Kingdom
• Research Services
• 700 & Above Employee
• Post Doctoral Scientist

  • Apr 2005 - Aug 2007


Walter and Eliza Hall Institute of Medical Research

• Australia
• Research
• 700 & Above Employee

• PHD

  • Jan 2001 - May 2005

  Melbourne, Australia PHD in T cell immunology. Studied the immunological checkpoints in dendritic cell licensing.



University of Melbourne

• Australia
• Higher Education
• 700 & Above Employee

• Bachelor of Science (Honours)

  • 1997 - 2000

  Melbourne, Australia